Skip to main content
. 2021 Nov;50(11):2161–2171. doi: 10.18502/ijph.v50i11.7570

Table 4:

Summary of the results of other outcome measures

Outcome indicator No. of trial P; I2 Model for meta-analysis Effect size 95%CI P
Recurrence rate 12 P=0.008; I2=56% RE OR=0.17 0.10–0.31 <0.001
Gastric emptying rate 7 P=0.03; I2=57% RE MD=11.97 9.90–14.03 <0.001
Motilin 2 P<0.001; I2=96% RE MD=−93.94 −142.34- −45.53 <0.001
Adverse effects rate 3 P=0.49; I2=0% FE OR=1.74 0.36–8.48 =0.49

RE, random-effects model; FE, fixed -effects model; OR, odds ratio; MD, mean difference.